Flow CAST® – Kinase Inhibtion Assay Citation: Advani, R.H. et al. Brutontyrosine kinase inhibitor ibrutinib(PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies. J ClinOncol. 2013 Jan 1; 31(1): 88-94. PMID: 23045577 "A decrease in anti–IgE-stimulated basophil degranulation was observed, consistent with the role of BTK downstream of the high-affinity IgE receptor."
Read more
- info@buhlmannlabs.ch
- +41 61 487 12 12
Non classifié(e)
Flow CAST® – Kinase Inhibtion Assay Citation: Winkler, DG et al. PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol. 2013 Nov 21;20(11):1364-74. doi: 10.1016/j.chembiol.2013.09.017. Epub 2013 Nov 7. PMID: 24211136. "These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting
Read more
Flow CAST® - Kinase Inhibtion Assay Citation: Lannutti, B.J. et al. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13; 117(2): 591-594. PMID: 20959606. "We have thus described the biochemical and cellular activity of CAL-101, a selective and potent inhibitor of p110δ; such targeted
Read more
HÔPITAUX UNIVERSITAIRES DE GENÈVE (HUG) INFINITI® Docteur Michela Rebsamen du Service de Médecine de Laboratoire des Hôpitaux Universitaires de Genève. ENTRETIEN AVEC MADAME REBSAMEN DES HÔPITAUX UNIVERSITAIRES DE GENÈVE Dans le cadre d’une évaluation de méthode, vous avez utilisé l’automate INFINITI® de AutoGenomics, quels sont les paramètres évalués ? Pourquoi ces paramètres? Lors de
Social Links